Durect (DRRX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

DRRX Durect

Watchlist

1.4800
+0.0500+3.50%

Close Aug 30 16:00 ET

1.4000
-0.0800-5.41%

Post 17:42 ET

45.94MMarket Cap-2426P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

DURECT Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Yahoo FinanceAug 16 09:29 ET
Express News | DURECT Corp - Files for Mixed Shelf Offering of up to $250 Mln- SEC Filing
ReutersAug 14 17:03 ET
Durect | 10-Q: Q2 2024 Earnings Report
SEC announcementAug 14 16:08 ET · Announcements
Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS), Durect (DRRX) and Globus Medical (GMED)
TipRanksAug 14 06:40 ET · Ratings
Earnings Call Summary | Durect(DRRX.US) Q2 2024 Earnings Conference
moomoo AIAug 13 23:33 ET · Conference Call
DURECT Corporation (DRRX) Q2 2024 Earnings Call Transcript
Earnings Call TranscriptsAug 13 20:42 ET

Comments

Meltyy

May 22 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

Trytosaveabit

May 21 07:02

News

$Durect (DRRX.US)$ Reuters· 1 min ago
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis

Novel Therapeutics Company Forms Strategic Collaboration Agreement

DURECT Corporation and Charles River Laboratories: A Strategic Alliance Set to Revolutionize the Biopharmaceutical Industry.
In a significant move within the biopharmaceutical industry, DURECT Corporation (DRRX) has entered into a co-marketing and collaboration agreement with Charles River Laboratories International, Inc. This alliance, announced on March 4, 2024, is set to jointly market and commercialize the ALZET Osmotic Pumps ...

Analyst Rating

No Data

Price Target

No Data

Overall

DRRX Durect

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target